Morbus Dupuytren/Morbus Ledderhose

  • Michael Heinrich Seegenschmiedt
Part of the Medical Radiology book series (MEDRAD)


The digitopalmar contracture named after Guillaume Dupuytren (1832, 1834) [36, 37] and the corresponding digito-plantar contracture named after Georg Ledderhose (1897) [91] are fibrous, proliferative hyperplastic disorders of pre-existing connective tissue structures of the fascia of the fingers and palm or the toes and sole, respectively. However, in Morbus Dupuytren (MD) and Morbus Ledderhose (ML), the digitopalmar and digitoplantar changes are not just singular afflictions, but part of a systemic connective tissue disorder [41], which is confirmed by subtle biochemical changes and obvious ectopic fibrous deposits, which are located, for example, above the dorsal proximal interphalangeal joints (= knuckle pads), on the auricular helix, the hand wrist, the elbow and inside the penis (= Morbus Peyronie). These tissue changes are histologically identical, but all efforts to identify a single cause of this generalized disorder have failed, and numerous hypotheses about the disease onset and progression have been published, but a simple and straightforward explana tion is still missing.


Morbus Dupuytren (Dupuytren’s Disease/Contracture) Morbus Ledderhose Palmar Fibromatosis Plantar Fibromatosis Spontaneous Development Medical Treatment Radiotherapy Hand Surgery Foot Surgery Clinical Trial 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Adamietz B, Sauer R (2000) Radiotherapy is effective in early stage Dupuytren’s contracture (ESDC). Int J Radiât Oncol Biol Phys 48 (suppl):243 (abstract)CrossRefGoogle Scholar
  2. 2.
    Adamietz B, Keilholz L, Grünert J, Sauer R (2001) Radiotherapy in early stage Dupuytren’s contracture. Strahlenther Onkol 177:604–610PubMedCrossRefGoogle Scholar
  3. 3.
    Allen PW (1977) The fibromatoses: a clinicpathologic classification based on 140 cases. Am J Surg Pathol 1:255–270PubMedCrossRefGoogle Scholar
  4. 4.
    Allen RA, Woolner LB, Ghormley RK (1955) Soft tissue tumors of the sole with special reference to plantar fibromatosis. J Bone Joint Surg 37A: 14–28Google Scholar
  5. 5.
    Allieu Y (1988) La “paume ouverte” dans le traitement de maladie de Dupuytren. Technique et indications. Rev Chir Orthop 74 (Suppl 2):46–49Google Scholar
  6. 6.
    Alman BA, Naber SP, Terek RM, Jiranek WA, Goldber MJ, Wolfe H (1995) Platelet-derived growth factor in fibrous musculoskeletal disorders: a study of pathologic tissue sections and in vitro primary cell cultures. J Orthop Res 13:67–77PubMedCrossRefGoogle Scholar
  7. 7.
    Aluisio FV, Mair SD, Hall RL (1996) Plantar fibromatosis: treatment of primary and recurrent lesions and factors associated with recurrence. Foot & Ankle Int 17:672–678Google Scholar
  8. 8.
    Attali P, Ink O, Pelletier G, Vernier C, Jean F, Moulton L, Etienne J-P (1987) Dupuytren’s contracture, alcohol consumption and chronic liver disease. Arch Int Med 147:1065–1067CrossRefGoogle Scholar
  9. 9.
    Aviles E, Arlene M, Miller T (1971) Plantar fibromatosis. Surgery 69:117–120PubMedGoogle Scholar
  10. 10.
    Badalamente MA, Samson SP, Hurst C, Down A, Miyasaka K, Brook S (2000) The role of transforming growth factor beta in Dupuytren’s disease. J Hand Surg 21A:210–215Google Scholar
  11. 11.
    Badalamente MA, Hurst C (2000) Enzyme injection as non-surgical treatment of Dupuytren’s disease. J Hand Surg 25A:629–636Google Scholar
  12. 12.
    Baird_KS, Crossan JF, Ralston SH (1993) Abnormal growth factor and cytokine expression in Dupuytren’s contracture. J Clin Pathol 46:425–428PubMedCrossRefGoogle Scholar
  13. 13.
    Benson LS, Williams CS, Kable M (1998) Dupuytren’s contracture. J Am Acad Orthop Surg 6:24–35PubMedGoogle Scholar
  14. 14.
    Berndt A, Kosmehl H, Katenkamp D, Tauchmann V (1994) Appearance of the myo-fibroblastic phenotype in Dupuytren’s disease is associated with a fibronectin, laminin, collagen type I and tenascin extracellular matrix. Pathobiology 62:55–58PubMedCrossRefGoogle Scholar
  15. 15.
    Blume PA, Courtright DJ, Nierni WJ, Gorecki G (1997) Fibrosarcoma of the foot: a case presentation and review of the literature. J Foot Ankle Surg 36:54–54Google Scholar
  16. 16.
    Bower M, Nelson M, Gozzard BG (1990) Dupuytren’s contracture in patients infected with HIV. Br Med J 300:164–165CrossRefGoogle Scholar
  17. 17.
    Brenner P, Mailänder P, Berger A (1994) Epidemiology of Dupuytren’s disease. In: Berger A, Delbrück A, Brenner P, Hinzmann R (eds) Dupuytren’s disease-pathobio-chemistry and clinical management. Springer, Berlin, Heidelberg, pp 244–254Google Scholar
  18. 18.
    Brenner P, Sachse C, Reichert B, Berger A (1996) Expression von diversen monoklonalen Antikörpern im Knoten-und Strangstadium des Morbus Dupuytren. Handchir Mikrochir Plast Chir 28:322–327PubMedGoogle Scholar
  19. 19.
    Brenner P, Krause-Bergmann A, Ha Van V (2001) Die Dupuytren’sche Kontraktur in Norddeutschland-Epidemiologische Erfassungsstudie an Hand von 500 Fällen. Unfallchirurg 104:303–311PubMedCrossRefGoogle Scholar
  20. 20.
    Brenner P, Rayan GM (2003) Dupuytren’s disease. A concept of surgical treatment. ISBN 3-211-83656-X, Springer, Wien New York, pp 80–81Google Scholar
  21. 21.
    Brotherston TM, Balakrishanan C, Milner RH, Brown HG (1994) Long-term follow-up of dermatofasciectomy for Dupuytren’s contracture. Br J Plast Surg 47:440–447PubMedCrossRefGoogle Scholar
  22. 22.
    Buck-Gramcko D, Hoffmann R, Neumann R (1992) Dupuytrensche Erkrankung. In: Buck-Gramcko D, Nigst H (eds) Die handchirurgische Sprechstunde. Hippokrates, Stuttgart, pp 75–82Google Scholar
  23. 23.
    Burch PRJ (1966) Dupuytren’s contracture: an auto-immune disease? J Bone Joint Surg 48B:312–319Google Scholar
  24. 24.
    Bürge AG, Hoy G, Regan P, Milne R (1997) Smoking, alcohol and the risk of Dupuytren’s contracture. J Bone Joint 79B:206–210CrossRefGoogle Scholar
  25. 25.
    Caroli A, Zanasi S, Marcuzzi A, Guerra D, Cristiani G, Ronchetti IP (1991) Epidemiological and structural findings supporting the fibromatous origin of dorsal knuckle pads. J Hand Surg 16B:258–262Google Scholar
  26. 26.
    Cavolo DJ, Sherwood GF (1982) Dupuytren’s disease of the plantar fascia. J Foot Surg 21:12–15PubMedGoogle Scholar
  27. 27.
    Classen DA, Hurst LN (1992) Plantar fibromatosis and bilateral flexion contractures: a review of the literature. Ann Plast Surg 28:475–478PubMedCrossRefGoogle Scholar
  28. 28.
    Conway H (1954) Dupuytren’s contracture. Am J Surg 87:101–119PubMedCrossRefGoogle Scholar
  29. 29.
    Cooper AP (1824) Dislocation form contraction of the tendon. In: Cooper A (ed) A treatise on dislocations and fractures of the joints (4th edn). Messr Longman, Hurst, Rees, Orme, Brown, and Green, London, pp 486–488Google Scholar
  30. 30.
    Crocker I (1999) Radiation therapy to prevent coronary artery restenosis. Sem Rad Oncol 9:134–143CrossRefGoogle Scholar
  31. 31.
    Dal Cin P, De Smet L, Sciot R, Van Damme B, Han de Berge H (1999) Trisomy 7 and trisomy 8 in dividing and non-dividing tumor cells in Dupuytren’s disease. Cancer Genet Ytogen 108:137–140CrossRefGoogle Scholar
  32. 32.
    De Maglio A, Timo R, Feliziani G (1996) Récidive ed estensioni nel morbo Dupuytren trattato con aponeur-ectomia selettiva. Revisioni clinica di 124 casi. Chir Organi Mov 86:43–48Google Scholar
  33. 33.
    Dominguez-Malagon HR, Alfeiran-Ruiz A, Chavarria-Xicotencatl P, Duran-Hernandez MS (1992) Clinical and cellular effects of colchicines in fibromatosis. Cancer 69:2478–2483PubMedCrossRefGoogle Scholar
  34. 34.
    Donato RR, Morrison WA (1996) Dupuytren’s disease in the feet causing flexion contractures in the toes. J Hand Surg 21B:364–366Google Scholar
  35. 35.
    Dufourmentel C, Beres J (1998) Radiodermatitis of the hand. In: Tubiana R (ed) The hand, vol III. WB Saunders, Philadelphia, London Toronto, pp 849–856Google Scholar
  36. 36.
    Dupuytren G (1832) Leçons orales de clinique chirurgicale faites a THotel-Dieu de Paris. Bailliere Libraire Paris, Londres pp 1–24Google Scholar
  37. 37.
    Dupuytren G (1834) Permanent retraction of the fingers, produced by an affection of the palmar fascia. Lancet 2:222–225Google Scholar
  38. 38.
    Dürr HR, Krödel A, Trouillier H, Lienemann A, Refior HJ (1989) Fibromatosis of the plantar fascia: Diagnosis and indications for surgical treatment. Foot Ankle Int 20:13–17Google Scholar
  39. 39.
    Early PF (1962) Population studies in Dupuytren’s contracture. J Bone Joint Surg 44B:602–613Google Scholar
  40. 40.
    Elliot D (1988) The early history of contracture of the palmar fascia. J Hand Surg 13B:246–253Google Scholar
  41. 41.
    Enzinger FM, Weiss SW (1994) Fibromatosis. In: Enzinger FM, Weiss SW (eds) Soft tissue tumors (3rd edn) St Louis, Mosby Year Book, pp 201–229Google Scholar
  42. 42.
    Falter E, Herndl E, Muhlbauer W (1991) Dupuytren’s contracture. When operate? Conservative preliminary treatment? Fortschr Med 109:223–226PubMedGoogle Scholar
  43. 43.
    Finck KW (1955) Zur Frage der Dupuytrenschen Fingerkontaktur und ihrer Behandlung mit Radium. Strahlentherapie 97:608–61Google Scholar
  44. 44.
    Finney R (1955) Dupuytren’s contracture. Brit J Radiol 28:610–613PubMedGoogle Scholar
  45. 45.
    Flint M (1990) Connective tissue biology. In: McFarlane RM, McGrouther DA, Flint M (eds) Dupuytren’s disease. Biology and treatment (The hand and upper limb series, vol 5). Churchill Livingstone, Edinburgh, pp 13–24Google Scholar
  46. 46.
    Flint M (1990) The genesis of the palmar lesion. In: McFarlane RM, McGrouther DA, Flint M (eds) Dupuytren’s disease. Biology and treatment (The hand and upper limb series, vol 5). Churchill Livingstone, Edinburgh, pp 136–154Google Scholar
  47. 47.
    Foucher G, Cornil C, Lenoble E (1992) La technique de la “plaie ouverte” dans la malarie de Dupuytren. Complications postoperatorie et résultats a plus de 5 ans. Chirurgie 118:189–196PubMedGoogle Scholar
  48. 48.
    Gabbiani G, Ryan GB, Majno G (1971) Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experimentia 27:549–550CrossRefGoogle Scholar
  49. 49.
    Geldmacher J (1994) Limited Fasciectomy. In: Berger A, Delbrück A, Brenner P, Hinzmann R (eds) Dupuytren’s disease. Springer, Berlin Heidelberg, pp 257–263Google Scholar
  50. 50.
    Godette GA, O’Sullivan M, Menelaus MB (1997) Plantar fibromatosis of the heel in children: a report of 14 cases. J Pediatr Orthop 17:16–17PubMedCrossRefGoogle Scholar
  51. 51.
    Gonzalez-Martinez R, Marin-Bertolin S, Amlorrortu-Velayos J (1985) Association between keloids and Dupuytren’s disease: case report. Br J Plast Surg 48:47–48CrossRefGoogle Scholar
  52. 52.
    Gösset J (1985) Dupuytren’s disease and the anatomy of the palmodigital aponeurosis. In: Hueston JT, Tubiana R (eds) Dupuytren’s disease. Churchill Livingstone, Edinburgh London Melbourne, pp 13–16Google Scholar
  53. 53.
    Goyrand G (1834) Nouvelle recherches sur la retraction permanente de doigts. Mem Acad (Paris) 3:489–490Google Scholar
  54. 54.
    Gudmundsson KG, Arngrimsson R, Arinbjarnarson S, Olafsson, J Jonsson J (1998) T-and B-lymphocyte subsets in patients with Dupuytren’s disease. J Hand Surg 23:724–727Google Scholar
  55. 55.
    Haedicke GJ, Sturim HS (1989) Plantar fibromatosis: an isolated disease. Plast Reconstr Surg 83:296–300PubMedCrossRefGoogle Scholar
  56. 56.
    Hall PN, Fitzgerald A, Sterne GD, Logan AM (1997) Skin replacement in Dupuytren’s disease. J Hand Surg 22B:193–197Google Scholar
  57. 57.
    Hankin FM, Eckenrode J, Louis DS (1986) Oestrogen and progesterone hormone receptors in Dupuytren’s disease. J Hand Surg HB:463–464Google Scholar
  58. 58.
    Herbst M, Regler G (1986) Dupuytrensche Kontraktur. Radiotherapie der Frühstadien. Strahlentherapie 161:143–147Google Scholar
  59. 59.
    Hesselkamp J, Schulmeyer M, Wiskemann A (1981) Röntgentherapie der Dupuytrenschen Kontraktur im Stadium I. Therapiewoche 31:6337–6338Google Scholar
  60. 60.
    Hill NA (1985) Dupuytren’s contracture. J Bone Joint Surg 67:1439–1443PubMedGoogle Scholar
  61. 61.
    Hueston JT (1960) The incidence of Dupuytren’s contracture. Med J Aust 47:999–1002Google Scholar
  62. 62.
    Hueston JT (1961) Limited fasciectomy for Dupuytren’s contracture. Plast Reconstr Surg 27:569–585CrossRefGoogle Scholar
  63. 63.
    Hueston JT (1963) The Dupuytren’s diathesis. In: Hueston JT (ed) Dupuytren’s contracture. E & S Livingstone, Edinburgh, pp 51–63Google Scholar
  64. 64.
    Hueston JT (1963) Dupuytren’s contracture. Williams & Wilkins, BaltimoreGoogle Scholar
  65. 65.
    Hueston JT (1971) Enzymatic fasciotomy. Hand 3:38–40PubMedCrossRefGoogle Scholar
  66. 66.
    Hueston JT (1974) Aetiological questions in Dupuytren’s contracture. In: Hueston JT, Tubiana R (eds) Dupuytren’s disease. Churchill Livingstone, Edinburgh London Melbourne, pp 29–36Google Scholar
  67. 67.
    Hueston JT (1976) Table top test. Med J Aust 63:189–190Google Scholar
  68. 68.
    Hueston JT (1984) Current state of treatment of Dupuytren’s disease. Ann Chir Main 3:81–92PubMedCrossRefGoogle Scholar
  69. 69.
    Hueston JT: Dupuytren’s contracture and occupation. J Hand Surg [Am] 1987; 12 A:657–658Google Scholar
  70. 70.
    Hurst LC, Badalamente M (1990) Associated diseases. In: McFarlane RM, McGrouther DA, Flint MH (eds) Dupuytren’s disease. Biology and treatment. Churchill Livingstone, Edinburgh London Melbourne, pp 253–260Google Scholar
  71. 71.
    Hurst LC (1996) Dupuytren’s fasciectomy. Zig-zag plasty technique. In: Blair WF, Steyers CM (eds) Techniques in hand surgery. Williams & Wilkins, Baltimore Philadelphia London, pp 519–529Google Scholar
  72. 72.
    Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Fujimoto M, Grotendorst GR, Takehara K (1996) Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106:729–733PubMedCrossRefGoogle Scholar
  73. 73.
    James J, Tubiana R (1952) La malarie de Dupuytren. Rev Chir Orthop 38:352–406PubMedGoogle Scholar
  74. 74.
    Jansen JTM, Broerse JJ, Zoetelief J, Klein C, Seegenschmiedt MH (2005) Estimation of the radiotherapy of benign diseases from shoulder to heel. Radiother Oncol 76:270–277PubMedCrossRefGoogle Scholar
  75. 75.
    Johnston RE, Collis S, Peckham NH, Rothstein AR (1992) Plantar fibromatosis: literature review and unique case report. J Foot Surg 31:400–406PubMedGoogle Scholar
  76. 76.
    Jordan GH (1998) Surgery for Peyronie’s disease. In: Libertino JA (ed) Reconstructive urologie surgery. Mosby, St. Louis Baltimore Carlsbad, pp 539–551Google Scholar
  77. 77.
    Joyce DA (1987) Oxygen radicals in disease. Adverse Drug Res Bull 127:476–479CrossRefGoogle Scholar
  78. 78.
    Keilholz L, Seegenschmiedt MH, Born AD, Sauer R (1997) Radiotherapy in the early stages of Dupuytren’s disease: indication, technique, long-term results. Strahlenther Onkol 173:27–35PubMedCrossRefGoogle Scholar
  79. 79.
    Keilholz L, Seegenschmiedt MH, Sauer R (1996) Radiotherapy for prevention of disease progression in early-stage Dupuytren’s contracture: initial and long-term results. Int J Radiât Oncol Biol Phys 36:891–897PubMedCrossRefGoogle Scholar
  80. 80.
    Ketchum LD, Hixsen FP (1987) Dermatofasciectomy and full-thickness grafts in the treatment of Dupuytren’s contracture. J Hand Surg 12A:659–663Google Scholar
  81. 81.
    Kischer CW, Thies AC, Chvapil M (1982) Perivascular myofibroblasts and microvascular occlusion in hyper-trophic scars and keloids. Hum Pathol 13:819–824PubMedCrossRefGoogle Scholar
  82. 82.
    Kischer CW, Speer DW (1986) Microvascular changes in Dupuytren’s contracture. J Hand Surg 9A:58–62Google Scholar
  83. 83.
    Köhler AH (1984) Die Strahlentherapie der Dupuytrenschen Kontraktur. Radiobiol Radiother 25:851–853Google Scholar
  84. 84.
    Lamb D (1981) Dupuytren’s disease. In: Lamb DW, Kuczynski K (eds) The practice of hand surgery. Blackwell, Oxford London, pp 635–648Google Scholar
  85. 85.
    Landers PA, Yu GV, White JM, Farrer AK (1993) Recurrent plantar fibromatosis. J Foot Ankle Surg 32:85–93PubMedGoogle Scholar
  86. 86.
    Lappi DA, Martineau D, Maher PA et al (1992) Basic fibroblast growth factor in cells deprived from Dupuytren’s contracture: synthesis, presence, and implication for treatment of the disease. J Hand Surg 17A:324–332Google Scholar
  87. 87.
    Latha MS, Vijayammal PL, Krupp PA (1991) Changes in the glycosaminoglycans and glycoproteins in the tissue in rat exposed to cigarette smoking. Artherosclerosis 31:49–54CrossRefGoogle Scholar
  88. 88.
    Lauf E, Freedman BM, Steinberg JS (1998) Autogenous free dermal fat grafts in the surgical approach to plantar fibromatosis. J Foot Ankle Surg 37:227–234PubMedCrossRefGoogle Scholar
  89. 89.
    Leclercq C, Tubiana R (1986) Resultat a long terme des aponevrectomies pur maladie de Dupuytren. Chirurgie, 112:194–197PubMedGoogle Scholar
  90. 90.
    Leclercq C, Hurst LC, Badalamente MA (2000) Non-surgical treatment. In: Tubiana R, Leclercq C, Hurst LC, Badalamente MA, Mackin EJ (eds) Dupuytren’s disease. Martin Dunitz, London Maiden Winnipeg Sao Paulo, pp 121–131Google Scholar
  91. 91.
    Ledderhose H (1897) Zur Pathologie der Aponeurose des Fusses und der Hand. Langenbecks Arch Klin Chir 55:694–712Google Scholar
  92. 92.
    Lee TK, Wapner KL, Hecht PJ (1993) Current concept review: plantar fibromatosis. J Bone Joint Surg 75A:1080–1083Google Scholar
  93. 93.
    Lermusiaux J-L, Lellouche H, Badois J-F, Kuntz D (1997) How should Dupuytren’sn disease be managed in 1997? Rev Rheum (Engl Ed) 64:775–776Google Scholar
  94. 94.
    Lexer E (1931) Die gesamte Wiederherstellungschirurgie. 2. Auflage, Barth, Leipzig, pp 837–844Google Scholar
  95. 95.
    Ling RSM (1963) The genetic factor in Dupuytren’s disease. Bone Joint Surg 45B:709–718Google Scholar
  96. 96.
    Liss GM, Stock SR (1996) Can Dupuytrenn’s contracture be work-related? Review of evidence. Am J Ind Med 29:521–532PubMedCrossRefGoogle Scholar
  97. 97.
    Little MP, Muirhead CR, Haylock RGE, Thomas JM (1999) Relative risks of radiation-associated cancer: comparison of second cancer in therapeutically irradiated populations with the Japanese atomic bomb survivors. Radiât Environ Biophys 38:267–283PubMedCrossRefGoogle Scholar
  98. 98.
    Lubahn JD, Lister GD, Wolfe T (1984) Fasciectomy of Dupuytren’s disease, comparison between the open-palm technique and wound closure. J Hand Surg 9A:53–58Google Scholar
  99. 99.
    Lubahn JD (1999) Open-palm technique and soft-tissue coverage in Dupuytren’s disease. Hand Clinics 15:127–136PubMedGoogle Scholar
  100. 100.
    Luck JV (1959) Dupuytren’s contracture: a new concept of pathogenesis correlated with surgical management. J Bone Joint Surg 41A:635–664Google Scholar
  101. 101.
    Lukacs S, Braun Falco O, Goldschmidt H (1978) Radiotherapy of benign dermatoses: indications, practice, and results. J Dermatol Surg Oncol 4:620–625PubMedGoogle Scholar
  102. 102.
    McFarlane RM (1988) Dupuytren’s contracture. In: Green DP (ed) Operative hand surgery, vol 1, Churchill Livingstone, New York Edinburgh London, pp 553–559Google Scholar
  103. 103.
    McFarlane RM, McGrouther DA, Flint MH (1990) Dupuytren’s disease. Biology and treatment. The hand and upper limb series, vol 5. Churchill Livingstone, Edinburgh London New YorkGoogle Scholar
  104. 104.
    McFarlane RM (1997) Dupuytren’s disease. J Hand Ther 10:8–13PubMedGoogle Scholar
  105. 105.
    McGrouther DA (1982) The microanatomy of Dupuytren’s contracture. Hand 13:215–236Google Scholar
  106. 106.
    McGrouther DA (1999) Dupuytren’s contracture. In: Green DP, Hotchkiss RN, Pederson WC (eds) Green’s operative hand surgery. Churchill Livingstone, New York Edinburgh London, pp 563–591Google Scholar
  107. 107.
    Menzel EJ, Piza H, Zielinski C, Ender AT, Steffen C, Millesi H (1979) Collagen types and anticollagen-antibodies in Dupuytren’s disease. Hand 11:243–248PubMedCrossRefGoogle Scholar
  108. 108.
    Messina A, Messina J (1991) The TEC (continuous extension technique) for severe Dupuytren’s contracture of the fingers. Ann Hand Surg 10:247–250Google Scholar
  109. 109.
    Micke O, Seegenschmiedt MH, and the German Working Group on Radiotherapy of Benign Diseases (2002) Consensus guidelines for radiation therapy of benign diseases: a multicenter approach in Germany. Int J Radiat Oncol Biol Phys 52:496–513PubMedGoogle Scholar
  110. 110.
    Mikkelsen OA (1972) The prevalence of Dupuytren’s disease in Norway. A study in a retrospective population sample of the municipality of Haugesund: Acta Chir Scand 138:695–700PubMedGoogle Scholar
  111. 111.
    Mikkelsen OA (1990) Epidemiology of a Norwegian population. In: McFarlane RM, McGrouther DA, Flint MH (eds) Dupuytren’ disease. Churchill Livingstone, Edinburgh Melbourne New York, pp 191–200Google Scholar
  112. 112.
    Millesi H (1965) Zur Pathogenese und Therapie der Dupuytrenschen Kontraktur (eine Studie an Hand von mehr als 500 Fällen). Ergebnisse der Orthopädie 47:51–101Google Scholar
  113. 113.
    Millesi H (1981) Dupuytren-Kontraktur. In: Nigst H, Buck-Gramcko D, Millesi H (eds) Handchirurgie, Band I. Allgemeines, Wahloperationen. Thieme, Stuttgart New York pp 15.01–15.57Google Scholar
  114. 114.
    Moermans JP (1991) Segmental aponeurectomy in Dupuytren’s disease. J Hand Surg 16B:243–254Google Scholar
  115. 115.
    Moermans JP (1996) Long-term results after segmental aponeurectomy for Dupuytren’s disease. J Hand Surg 21B:797–800Google Scholar
  116. 116.
    Mumenthaler M, Schliack H (1982) Läsionen peripherer Nerven. Thieme, StuttgartGoogle Scholar
  117. 117.
    Murell GAC, Murell TGC, Pilowsky EA (1987) A hypothesis for the resolution of Dupuytren’s contracture with allopurinol. Speculations in Science and Technology 10:107–11Google Scholar
  118. 118.
    Murell GAC, Francis MJO, Bromley L (1987) Free radicals and Dupuytren’s contracture. Br Med J 295:1373–1375CrossRefGoogle Scholar
  119. 119.
    Murrell GAC, Francis MJO, Howlett CR (1989) Dupuytren’s contracture, fine structure in relation to aetiology. J Bone Joint Surg 71B:367–372Google Scholar
  120. 120.
    Murrell GAC, Francis MJO; Bromley L (1990) Modulation of fibroblast proliferation by oxygen free radiacals. Biochem J 165:659–665Google Scholar
  121. 121.
    Murreil GAC (1992) An insight into Dupuytren’s contracture. Ann Roy Coll Surg (Engl) 74:156–161Google Scholar
  122. 122.
    Murreil GAC, Francis MJO (1994) Oxygen free radiacals and Dupuytren’s disease. In: Berger A, Delbrück A, Brenner P, Hinzmann R (eds) Dupuytren’s disease. Pathobiochemistry and clinical management. Springer, Berlin Heidelberg New York, pp 227–234Google Scholar
  123. 123.
    Mutsaers SE, Bishop JE, McGroutherG, Laurent GJ (1997) Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 29:5–17PubMedCrossRefGoogle Scholar
  124. 124.
    Noble J, Arafa M, Royle SG, McGeorge G, Crank S (1992) The association between alcohol, hepatic pathology and Dupuytren’s disease. J Hand Surg 17B:71–74Google Scholar
  125. 125.
    Norotte G, Apoil A, Travers V (1988) Resultat a plus de dix ans de la maladie de Dupuytren: A propos de cinquante-huit observation. Ann Chir Main 7:277–281PubMedCrossRefGoogle Scholar
  126. 126.
    Nyberg LM, Bias WB, Hochberg MC, Walsh PC (1982) Identification of an inherited form of Peyronie’s disease with autosomal dominant inheritance and association with Dupuytren’s contracture and histocompatibility B7 cross-reacting antigens. J Urol 128:48–52PubMedGoogle Scholar
  127. 127.
    Pal B, Griffiths ID, Anderson J, Dich WC (1987) Association of limited joint mobility with Dupuytren’s contracture in diabetes mellitus. J Rheumatol 14:582–585PubMedGoogle Scholar
  128. 128.
    Pentland AP, Anderson TF (1985) Plantar fibromatosis responds to intralesional steroids. J Am Acad Dermatl 12:212–214CrossRefGoogle Scholar
  129. 129.
    Pereira RS, Black CM, Turner SM, Spencer JD (1986) Antibodies to collagen types I-IV in Dupuytren’s contracture. J Hand Surg 11B:58–60Google Scholar
  130. 130.
    Pickren JW, Smith AG, Stevenson TW, Stout AP (1951) Fibromatosis of the plantar fascia. Cancer 4:846–856PubMedCrossRefGoogle Scholar
  131. 131.
    Platter F (1614) Observationum, in hominibus affectibus plerisque, corpori et animo, functionum laesione, dolore, aliave molestia et vitio incommodantibus, libri très. Liber primus. L. König, Basel, pp 137–145Google Scholar
  132. 132.
    Rabinowitz JL, Ostermann JR, Bora FW, Steffer J (1983) Lipid composition and de novo lipid biosynthesis of human palmar fat in Dupuytren’s disease. Lipids 18:371–373PubMedCrossRefGoogle Scholar
  133. 133.
    Rafter D, Kenny R, Gilmore M, Walsh CH (1980) Dupuytren’s contracture-a survey of a hospital population. Ir Med J 73:227–228PubMedGoogle Scholar
  134. 134.
    Rao GS, Luthra PK (1988) Dupuytren’s disease of the foot in children: a report of three cases. J Plast Surg 28:475–478Google Scholar
  135. 135.
    Rayan GM, Parizi M, Tomasek JJ (1996) Pharmacological regulation of Dupuytren’s fibroblast contraction in vitro. J Hand Surg Am 21:1065–1070PubMedCrossRefGoogle Scholar
  136. 136.
    Rodemann HP, Bamberg M (1995) Cellular basis of radiation induced fibrosis. Radiother Oncol 35:83–90PubMedCrossRefGoogle Scholar
  137. 137.
    Rodemann HP, Peterson HP, Schwenke K, von Wangenheim KH (1991) Terminal differentiation of human skin fibroblasts is induced by radiation. Scand Microsc 5:1135–1143Google Scholar
  138. 138.
    Rosenbloom AL, Silverstein JH (1996) Connective tissue and joint disease in diabetes mellitus. Endocrin Met North Amer 25:473–483CrossRefGoogle Scholar
  139. 139.
    Rubin P, Constine LS, Fajardo LF, Phillips TL, Wasserman TH (1996) Overview: late effects of normal tissue (LENT) scoring system. Int J Radiât Oncol Biol Phys 31:1041–1042CrossRefGoogle Scholar
  140. 140.
    Rubin P, Soni A, Williams JP (1999) The molecular and cellular biologic basis for radiation treatment of benign proliferative diseases. Sem Rad Oncol 9:203–214CrossRefGoogle Scholar
  141. 141.
    Rudolph R, Van de Berg J (1991) The myofibroblast in Dupuytren’s contracture. Hand Clin 7:683–692PubMedGoogle Scholar
  142. 142.
    Sammarco GJ, Mangone PG (2000) Classification and treatment of plantar fibromatosis. J Foot Ankle Int 21:563–569Google Scholar
  143. 143.
    Seegenschmiedt MH, Olschewski T, Guntrum F (2001) Optimierung der Radiotherapie beim Morbus Dupuytren: erste Ergebnisse einer kontrollierten Studie. Strahlenther Onkol 177:74–81PubMedCrossRefGoogle Scholar
  144. 144.
    Seegenschmiedt MH, Attassi M (2003) Strahlentherapie beim Morbus Ledderhose-Indikation und Ergebnisse. Strahlenther Onkol 179(12):847–853PubMedCrossRefGoogle Scholar
  145. 145.
    Sennwald GR (1990) Fasciectomy for treatment of Dupuytren’s disease and early complications. J Hand Surg 15A:755–761Google Scholar
  146. 146.
    Sinha A (1997) Dupuytren’s disease may extend beyond the wrist crease in continuity. J Bone Joint Surg 79B:211–212CrossRefGoogle Scholar
  147. 147.
    Skoog T (1948) Dupuytren’s contraction with special reference to aetiology and improved surgical treatment, its occurrence in epileptics. Acta Chir Scand 96 (Suppl): pl39Google Scholar
  148. 148.
    Smitt MC, Donaldson SS (1999) Radiation therapy for benign disease of the orbit. Sem Rad Oncol 9:179–189CrossRefGoogle Scholar
  149. 149.
    Snyder M (1980) Dupuytren’s contracture and plantar fibromatosis: is there more than a causal relationship? J Am Podiatry Assoc 70:410–415PubMedGoogle Scholar
  150. 150.
    Strickland JW, Idler RS, Creighton JC (1990) Dupuytren’s disease. Indiana Med 83:408–409PubMedGoogle Scholar
  151. 151.
    Stirpe F, Gasperi-Campani A, Barbieri L, Falasca A, Abbondanza A, Stevens WA (1983) Ribosome-inactivating proteins from the seed of Saponaria officinalis L. (soapwort) of Agrostemma githoga L. (corn cockle) and of Asparagus officinalis L. (asparagus), and from the latex of Hura crepitans L. (sandbox tree). Biochem J 216:617–625PubMedGoogle Scholar
  152. 152.
    Suit H, Spiro I (1999) Radiation treatment of benign mesenchymal disease. Sem Rad Oncol 9:171–178CrossRefGoogle Scholar
  153. 153.
    Terek RM, Jiranek WA, Goldberg MJ, Wolfe HJ, Alman BA (1995) The expression of platelet-derived growth-factor gene in Dupuytren contracture. J Bone Joint Surg 77A:l–9Google Scholar
  154. 154.
    Tomasek JJ, Schultz RJ, Haaksma CJ (1987) Extracellular matrix-cytoskeletal connections at the surface of the specialized contractile fibroblast (myofibroblast) in Dupuytren disease. J Bone Joint Surg 69A:1400–1407Google Scholar
  155. 155.
    Tomasek J, Rayan GM (1995) Correlation of alpha-smooth muscle actin expression and contraction in Duputren’s disease fibroblasts. J Hand Surg Am 20:450–455PubMedCrossRefGoogle Scholar
  156. 156.
    Tonkin MA, Burke FD, Varian JPW (1984) Dupuytren’s contracture: a comparative study of fasciectomy and dermatofasciectomy in 100 patients. J Hand Surg 1984; 9B:156–162Google Scholar
  157. 157.
    Tripuranemi P, Giap H, Jani S (1999) Endovascular brachytherapy for peripheral vascular disease. Sem Rad Oncol 9:190–202CrossRefGoogle Scholar
  158. 158.
    Tubiana R, Micron J (1961) Evaluation chiffrée de la deformation dans la maladie de Dupuytren. Mem Acad Chir 87:887–888Google Scholar
  159. 159.
    Tubiana R, Michon J, Thomine JM (1966) Evaluation chiffrée des deformations dans la maladie de Dupuy tren. In: Maladie du Dupuytren (monographies du G.E.M.) Paris, Expansion Scientifique Française, Paris, pp 86Google Scholar
  160. 160.
    Tubiana R, Leclercq C (1986) Les recives de la malarie de Dupuytren. Tubiana R, Hueston JT (eds) La maladie de Dupuytren. Expansion Scientifique Française, Paris, pp 111–114Google Scholar
  161. 161.
    Tubiana R (1999) Dupuytren’s disease of the radial side of the hand. Hand Clinics 15:149–159PubMedGoogle Scholar
  162. 162.
    Ushijima M, Tsuneyoshi M, Enjoji M (1984) Dupuytren type fibromatoses. A clinico-pathologic study of 62 cases. Acta Pathol Jpn 34:991–1001PubMedGoogle Scholar
  163. 163.
    Viljanto JA (1973) Dupuytren’s contracture: A review. Semin Arthritis Rheum 3:155–176CrossRefGoogle Scholar
  164. 164.
    Vogt HJ, Hochschau L (1980) Behandlung der Dupuytrenschen Kontraktur. Munch Med Wschr 122:125–130Google Scholar
  165. 165.
    Wapner KL, Ververell PA, Moore JH et al (1995) Plantar fibromatosis: a review of primary and recurrent surgical treatment. Foot Ankle Int 16:548–551PubMedGoogle Scholar
  166. 166.
    Wasserburger K (1956) Therapie der Dupuytrenschen Kontraktur. Strahlenther 100:546–560Google Scholar
  167. 167.
    Weinzierl G, Flügel M, Geldmacher J (1993) Fehlen der Effektivität der alternativ nicht-chirurgischen Behandlungsverfahren beim Morbus Dupuytren. Chirurg 64:492–494PubMedGoogle Scholar
  168. 168.
    Wheeler ES, Meals S (1981) Dupuytren’s diathesis: abroad spectrum disease. Plast Reconstr Surg 771–783Google Scholar
  169. 169.
    White JM, Heckler FR (1990) Oxygen free radicals and wound healing. Clin Plastic Surg 17:473–484Google Scholar
  170. 170.
    Woodruff MJ, Waldram MA (1998) A clinical grading system for Dupuytren’s contracture. J Hand Surg 13:67–72Google Scholar
  171. 171.
    Woolridge WE (1988) Four related fibrosing diseases. When you find one, look for another. Postgrad Med 84:269–271Google Scholar
  172. 172.
    Yost J, Winter T, Fett H (1955) Dupuytrens contracture. A statistical study. Am J Surg 90:568–571PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • Michael Heinrich Seegenschmiedt
    • 1
  1. 1.Dept. of Radiation Oncology and Therapeutic RadiologyAlfried Krupp HospitalEssenGermany

Personalised recommendations